Jeena Sikho Lifecare Limited has informed the Exchange regarding Outcome of Nomination and Remuneration Committee ("NRC") Meeting held on January 01, 2026.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Nomination and Remuneration Committee of Jeena Sikho Lifecare, at a meeting on January 1, 2026, approved the grant of 2,18,875 stock options to 1,176 eligible employees under the company's ESOP 2025 scheme. Each option is convertible into one equity share of ₹2 face value, with the exercise price fixed at ₹2 per option. The scheme is fully compliant with SEBI's Share Based Employee Benefits Regulations, 2021. The company stated the grant is aimed at employee motivation and long-term value creation. Options, once vested, can be exercised within one year from the date of vesting.
This is a routine ESOP grant with a modest size of 2.18 lakh options, meaning any future dilution is limited. For shareholders, it signals management's effort to retain and incentivise employees by aligning them with long-term shareholder value, with no immediate impact on share price since options are not yet exercised.